SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. Mabashi-Asazuma, C.-W. Kuo, K.-H. Khoo, D. L. Jarvis, A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells, Glycobiology, 2014, 24, 3, 325

    CrossRef

  2. 2
    Yunzhi Pan, Li Xiao, Alice S. S. Li, Xu Zhang, Pierre Sirois, Jia Zhang, Kai Li, Biological and Biomedical Applications of Engineered Nucleases, Molecular Biotechnology, 2013, 55, 1, 54

    CrossRef

  3. 3
    Xiaotian Zhong, Jill F. Wright, Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications, International Journal of Cell Biology, 2013, 2013, 1

    CrossRef

  4. 4
    Soo Min Noh, Madhavi Sathyamurthy, Gyun Min Lee, Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production, Current Opinion in Chemical Engineering, 2013, 2, 4, 391

    CrossRef

  5. 5
    Natalie R. Sealover, Angela M. Davis, Jeanne K. Brooks, Henry J. George, Kevin J. Kayser, Nan Lin, Engineering Chinese Hamster Ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN)—mediated gene knockout of mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (Mgat1), Journal of Biotechnology, 2013, 167, 1, 24

    CrossRef

  6. 6
    Seshu Tummala, Michael Titus, Lee Wilson, Chunhua Wang, Carlo Ciatto, Greg Thill, Donald Foster, Chen Li, Zoltan Szabo, Andras Guttman, Brian Bettencourt, Muthuswamy Jayaraman, Jack Deroot, David Kocisko, Stuart Pollard, Klaus Charisse, Satya Kuchimanchi, Greg Hinkle, Stuart Milstein, Rachel Meyers, Shiaw-Lin Wu, Barry L. Karger, Anthony Rossomando, Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals, Biotechnology Progress, 2013, 29, 2
  7. 7
    J. Hauschild-Quintern, B. Petersen, G. J. Cost, H. Niemann, Gene knockout and knockin by zinc-finger nucleases: current status and perspectives, Cellular and Molecular Life Sciences, 2013, 70, 16, 2969

    CrossRef

  8. 8
    Steven CL Ho, Yen Wah Tong, Yuansheng Yang, Generation of monoclonal antibody-producing mammalian cell lines, Pharmaceutical Bioprocessing, 2013, 1, 1, 71

    CrossRef

  9. 9
    Jay J. Listinsky, Gene P. Siegal, Catherine M. Listinsky, Glycoengineering in cancer therapeutics, Anti-Cancer Drugs, 2013, 24, 3, 219

    CrossRef

  10. 10
    Sandra Cristea, Yevgeniy Freyvert, Yolanda Santiago, Michael C. Holmes, Fyodor D. Urnov, Philip D. Gregory, Gregory J. Cost, In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration, Biotechnology and Bioengineering, 2013, 110, 3
  11. 11
    Glen R. Bolton, Margaret E. Ackerman, Austin W. Boesch, Separation of nonfucosylated antibodies with immobilized FcγRIII receptors, Biotechnology Progress, 2013, 29, 3
  12. 12
    Sang Taek Jung, Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies, Biotechnology and Bioprocess Engineering, 2013, 18, 4, 625

    CrossRef

  13. 13
    Lianchun Fan, Christopher C Frye, Andrew J Racher, The use of glutamine synthetase as a selection marker: recent advances in Chinese hamster ovary cell line generation processes, Pharmaceutical Bioprocessing, 2013, 1, 5, 487

    CrossRef

  14. 14
    Anne Louise Tølbøll Sørensen, Henrik Clausen, Hans H. Wandall, Carbohydrate clearance receptors in transfusion medicine, Biochimica et Biophysica Acta (BBA) - General Subjects, 2012, 1820, 11, 1797

    CrossRef

  15. 15
    Amanda M Lanza, Joseph K Cheng, Hal S Alper, Emerging synthetic biology tools for engineering mammalian cell systems and expediting cell line development, Current Opinion in Chemical Engineering, 2012, 1, 4, 403

    CrossRef

  16. 16
    Xiaotian Zhong, Cecilia Cooley, Nilufer Seth, Z. Sean Juo, Ella Presman, Nicole Resendes, Ravi Kumar, Martin Allen, Lidia Mosyak, Mark Stahl, Will Somers, Ronald Kriz, Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N-acetylglucosaminyltransferase I, Biotechnology and Bioengineering, 2012, 109, 7
  17. 17
    Lianchun Fan, Ibrahim Kadura, Lara E. Krebs, Christopher C. Hatfield, Margaret M. Shaw, Christopher C. Frye, Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells, Biotechnology and Bioengineering, 2012, 109, 4
  18. 18
    M. Butler, A. Meneses-Acosta, Recent advances in technology supporting biopharmaceutical production from mammalian cells, Applied Microbiology and Biotechnology, 2012, 96, 4, 885

    CrossRef

  19. 19
    Therapeutic Antibody Engineering, 2012,

    CrossRef

  20. 20
    Therapeutic Antibody Engineering, 2012,

    CrossRef

  21. 21
    Sang Taek Jung, Tae Hyun Kang, William Kelton, George Georgiou, Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy, Current Opinion in Biotechnology, 2011, 22, 6, 858

    CrossRef

  22. 22
    Philippe Taupin, Cell lines expressing mutant FX proteins to generate proteins with reduced rate of fucosylation: WO2010/141478, Expert Opinion on Therapeutic Patents, 2011, 21, 7, 1143

    CrossRef

  23. 23
    J. Hauschild, B. Petersen, Y. Santiago, A.-L. Queisser, J. W. Carnwath, A. Lucas-Hahn, L. Zhang, X. Meng, P. D. Gregory, R. Schwinzer, G. J. Cost, H. Niemann, Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases, Proceedings of the National Academy of Sciences, 2011, 108, 29, 12013

    CrossRef

  24. 24
    Philippe Taupin, Modulation of GDP-fucose level for generating proteins with reduced rate of fucosylation (WO2010141855), Expert Opinion on Therapeutic Patents, 2011, 21, 9, 1497

    CrossRef

  25. 25
    Jeff Jia Cheng Hou, Joe Codamo, Warren Pilbrough, Benjamin Hughes, Peter P Gray, Trent P Munro, New frontiers in cell line development: challenges for biosimilars, Journal of Chemical Technology and Biotechnology, 2011, 86, 7
  26. 26
    An XIAO, Ying-Ying HU, Wei-Ye WANG, Zhi-Peng YANG, Zhan-Xiang WANG, Peng HUANG, Xiang-Jun TONG, Bo ZHANG, Shuo LIN, Progress in zinc finger nuclease engineering for targeted genome modification, Hereditas (Beijing), 2011, 33, 7, 665

    CrossRef

  27. 27
    Fyodor D. Urnov, Edward J. Rebar, Michael C. Holmes, H. Steve Zhang, Philip D. Gregory, Genome editing with engineered zinc finger nucleases, Nature Reviews Genetics, 2010, 11, 9, 636

    CrossRef